The University of Arizona
Map Home
Loading...
Adjust height of sidebar
KMap

Grant

A Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Fazirsiran in the Treatment of Alpha-1 Antitrypsin Deficiency?associated Liver Disease With Metavir

Sponsored by PPD Investigator Services, LLC.

Active
$1.6M Funding
5 People
External

Related Topics

People